Dietary composition during fetal and neonatal life affects neuropeptide Y functioning in adult offspring.
The aim of this study was to examine the impact of maternal diet during the gestation and lactation periods on the neuropeptide Y (NPY) system in adult offspring. Male Long-Evans rats were obtained from dams fed either on a well-balanced diet (C), a high carbohydrate diet (HC) or a high-fat diet (HF) and fed themselves on the well-balanced diet for their whole life. At 6 months of age, their feeding response to various doses of NPY injected in the lateral brain ventricle was measured in one group and NPY concentrations in microdissected nuclei of the hypothalamic were measured in a second group. The HF rats were lighter than the two other groups (P<0.001). The control rats showed a typical dose-dependent feeding response to NPY. The HC rats showed a continuous increase in the response, starting at the intermediate dose (1.0 microg) only while the HF rats had a maximal response at the lowest dose (0.5 microg). The HF rats ate twice as much as the HC rats at the lowest dose tested 1 h after injection (4.4+/-0.6 vs. 2.7+/-0.4 g; P<0.05), showing therefore the greatest sensitivity to NPY. This change in the sensitivity was not related to hypothalamic NPY concentration as it was not modified in the arcuate and paraventricular nuclei. The diet imposed on the mother could have long-lasting effects on body weight regulation of the offsprings and alter the NPY system likely through modifications at the receptor level.
Kozak
R
R
INSERM U.308, Mécanismes de Régulation du Comportement Alimentaire, 38 Rue Lionnois, 54000, Nancy, France.
Burlet
A
A
Burlet
C
C
Beck
B
B
D000824:Animal Nutritional Physiological Phenomena; D000818:Animals; D000831:Animals, Newborn; D001111:Arcuate Nucleus of Hypothalamus / Q000737:chemistry / Q000187:drug effects / Q000254:growth & development; D001786:Blood Glucose; D001835:Body Weight; D004040:Dietary Carbohydrates / Q000494:pharmacology*; D004041:Dietary Fats / Q000494:pharmacology*; D004302:Dorsomedial Hypothalamic Nucleus / Q000737:chemistry / Q000187:drug effects / Q000254:growth & development; D005247:Feeding Behavior / Q000187:drug effects; D005260:Female; D007026:Hypothalamic Area, Lateral / Q000737:chemistry / Q000187:drug effects / Q000254:growth & development; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood; D008297:Male; D009478:Neuropeptide Y / Q000032:analysis / Q000494:pharmacology*; D010286:Paraventricular Hypothalamic Nucleus / Q000737:chemistry / Q000187:drug effects* / Q000254:growth & development*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D020318:Rats, Long-Evans; D013493:Suprachiasmatic Nucleus / Q000737:chemistry / Q000187:drug effects / Q000254:growth & development; D014697:Ventromedial Hypothalamic Nucleus / Q000737:chemistry / Q000187:drug effects / Q000254:growth & development
D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D007328:Insulin; D009478:Neuropeptide Y